Trial Profile
Kanglaite Injection combined with Gemzar (KG) versus Gemzar alone (G) in treating local advanced and metastatic pancreatic cancer: a multicenter randomized control clinical study.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Apr 2016
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Kanglaite (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 07 Jun 2011 Results presented at the 47th Annual Meeting of the American Society of Clinical Oncology.
- 14 Aug 2010 New trial record